<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04008680</url>
  </required_header>
  <id_info>
    <org_study_id>HiREB 7607</org_study_id>
    <nct_id>NCT04008680</nct_id>
  </id_info>
  <brief_title>Changes in Reliability When Assessing Multiple Patient-Reported Outcome Measures</brief_title>
  <acronym>CRAM-PROMs</acronym>
  <official_title>Collection of Remotely Administered Multiple Patient-Reported Outcome Measures (CRAM-PROMs) in Orthopaedic Trauma: Assessment of the Impact of Quantity on Quality</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hamilton Health Sciences Corporation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hamilton Health Sciences Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates how reliability of patient reported outcomes can be affected with&#xD;
      questionnaire burden and and the number of questionnaires given to study participants.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of the study is to determine if the number of remotely administered&#xD;
      questionnaires completed by fracture patients affects the psychometric properties of a&#xD;
      questionnaire itself. We will assess the internal consistency of the EuroQuol Five Dimension&#xD;
      - Five Level (EQ-5D-5L) Health Survey questionnaire as more questionnaires are applied.&#xD;
&#xD;
      The secondary objective is to evaluate how the number of questionnaires and the time it takes&#xD;
      to complete them impact patient's preferences and values. We will measure the time taken by&#xD;
      each participant to complete the EQ-5D-5L questionnaire to evaluate if it changes&#xD;
      meaningfully as the number of questionnaires given to participants' increases. Additionally,&#xD;
      we will assess patient preferences and values by asking how well the remotely collected PROMs&#xD;
      reflect their health status, and how this changes relative to the number of questionnaires&#xD;
      administered.&#xD;
&#xD;
      Our hypothesis is that there is a progressive decline in psychometric properties in the&#xD;
      EQ-5D-5L, both in reliability and validity, as we increase the number of questionnaires given&#xD;
      to participants. We also hypothesize that the time to complete the ED-5D-5L will increase as&#xD;
      the number of questionnaires given to participants' increases, and that there is a threshold&#xD;
      at which the patient feels there are no additional value to completing additional remote&#xD;
      PROMS to adequately reflect their health status.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 17, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>4 group randomized clinical trial</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reliability and validity of the EQ-5D-5L</measure>
    <time_frame>Day 1</time_frame>
    <description>The questionnaire selected to analyze reliability in our population is the EQ-5D-5L.This well-known, generic, patient-reported health questionnaire is frequently used in musculoskeletal research and has shown to have a good internal consistency. We will compute the Cronbach's alpha coefficient for the EQ-5D-5L questionnaire. We will contrast these results to analyze if there is any difference in the values obtained from the answers of the EQ-5D-5L questionnaire between the four groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to completion</measure>
    <time_frame>Day 1</time_frame>
    <description>Time to complete the questionnaire. We will collect data (through electronic software) on time to completion of the EQ-5D-5L questionnaire. We hypothesize that as patients are asked to complete more surveys, patients will fatigue as the research burden increases and take longer to complete the surveys. Data will be collected in minutes, and the mean time to completion will be compared across groups through analysis of variance tests.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>PROM</condition>
  <arm_group>
    <arm_group_label>Low response burden</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participants will be assigned to complete only the EQ-5D-5L questionnaire.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low to medium response burden</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participants will be assigned to complete the General Anxiety Disorder-7 (GAD-7) questionnaire first, followed by the EQ-5D-5L questionnaire.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medium to high response burden</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participants will be assigned to complete the Pain Catastrophizing Scale (PCS) questionnaire first, followed by the GAD-7, and lastly the EQ-5D-5L questionnaire.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High response burden</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participants will be assigned to complete the Brief Pain Inventory (BPI) questionnaire first, followed by the PCS secondly, the GAD-7 third, and lastly the EQ-5D-5L questionnaire.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>EQ-5D-5L survey internal consistency</intervention_name>
    <description>To see how increasing the number of questionnaires affects the internal consistency of the EQ-5D-5L.</description>
    <arm_group_label>High response burden</arm_group_label>
    <arm_group_label>Low response burden</arm_group_label>
    <arm_group_label>Low to medium response burden</arm_group_label>
    <arm_group_label>Medium to high response burden</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. The patient presents to the in-person or virtual fracture clinic for his/her own&#xD;
             appointment.&#xD;
&#xD;
          2. The patient has a fracture that is being managed either operatively or&#xD;
             non-operatively.&#xD;
&#xD;
          3. Fracture occurred in the past 6 months.&#xD;
&#xD;
          4. The patient is 18 years of age or older.&#xD;
&#xD;
          5. The patient is able to read, understand, and write in English.&#xD;
&#xD;
          6. Patient provides informed, verbal or written consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. The patient is considered too ill or injured to participate in the study.&#xD;
&#xD;
          2. The patient is cognitively impaired, intoxicated or otherwise unable to provide&#xD;
             consent or participate in the study.&#xD;
&#xD;
          3. The patient is co-enrolled in another study requiring completion of multiple&#xD;
             additional PROMs.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francesc Antoni Marcano-Fernandez, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Herman Johal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gina Del Fabbro, BPH</last_name>
    <phone>2898080709</phone>
    <email>delfabbg@mcmaster.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carlos Prada</last_name>
    <phone>6477818694</phone>
    <email>pradac@mcmaster.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hamilton Health Sciences - General Site</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gina Del Fabbro, BPH</last_name>
      <phone>2898080709</phone>
      <email>delfabbg@mcmaster.ca</email>
    </contact>
    <contact_backup>
      <last_name>Jodi Gallant</last_name>
      <email>gallaj4@mcmaster.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Herman Johal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 26, 2019</study_first_submitted>
  <study_first_submitted_qc>July 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 5, 2019</study_first_posted>
  <last_update_submitted>July 26, 2021</last_update_submitted>
  <last_update_submitted_qc>July 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>consistency</keyword>
  <keyword>reliability</keyword>
  <keyword>burden</keyword>
  <keyword>response</keyword>
  <keyword>methodology</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Undecided. Data collected (Internal consistency, demographics etc will be shared previous agreement)</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

